A Phase I Study to Assess PSMA+ and PSMA- Tumour Lesions

NCT05836623 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

5

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced and/or Metastatic Solid Tumours

Interventions

DRUG: Radiolabelled CB307
DRUG: CB307

Sponsor

Crescendo Biologics Ltd.

Collaborators

[object Object]